Loading...
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Among patients with type 2 diabetes, continuous glucose monitoring is associated with better glucose control, according to an industry-funded study in the Annals of Internal Medicine.
Nearly 160 adults with type 2 diabetes requiring multiple daily insulin injections and baseline hemoglobin A1c levels of 7.5%–9.9% were randomized to either continuous glucose monitoring or usual care. At 24 weeks, the continuous monitoring group had a greater reduction in HbA1c level than did the control group (-0.8% vs. -0.5%). The two groups did not differ in adverse events or quality of life.
Editorialists write that clinicians should carefully select candidates for treatment based on "who may achieve maximum clinical utility, such as those who have [type 1 diabetes], high risk for hypoglycemia, and high medical literacy; those who adhere to medical device instructions; and now patients with [type 2 diabetes] receiving multiple daily injections of insulin."
Comment
LINK(S):
Annals of Internal Medicine article (Free abstract)
Annals of Internal Medicine editorial (Subscription required)
Background: NEJM Journal Watch General Medicine coverage of continuous glucose monitoring in type 1 diabetes (Free)